Medicines List | TchaikaPharma

Co-Valstor

Description

Co-Valstor contains two active pharmaceutical ingredients – Valsartan and Hydrochlorthiazide, which helps to control high blood pressure (hypertension). Valsartan belongs to a group of medicines called angiotensin II receptor blockers”, whose effect is expressed in blood vessels and blood pressure. Hydrochlorthiazide belongs to the group of diuretics, whose effect is to increase urine output, which also lowers blood pressure.

Indications

– Treatment of essential hypertension in adults

Subject to medical prescription

Pharmaceutical form: 160/12.5 mg x 30 film-coated tablets
NHIF code: CG 031

ICD: I10, I11.0, I11.9, I12.0, I12.9, I13.0, I13.1, I13.2

Pharmaceutical form: 160/25 mg x 30 film-coated tablets
NHIF code: CG 019

ICD: I10, I11.0, I11.9, I12.0, I12.9, I13.0, I13.1, I13.2

Atorva

Description

Atorvastatin belongs to a group of medicines known as statins, which regulate lipids (fats). It is used to reduce lipids known as cholesterol and triglyceride levels when a diet low in fat and changes in lifestyle alone are insufficient. Even with normal levels of cholesterol, Atorva can reduce the risk of heart disease.

Indications

– Hypercholesterolemia

– Prophylaxis of cardiovascular disease

Subject to medical prescription

Pharmaceutical form: 10 mg x 30 film-coated tablets

NHIF code: CF996

ICD: I20.0; I20.1; I20.8; I20.9; I25.5; I69.0; I69.1; I69.2; I69.3; I69.4; I69.8

Pharmaceutical form: 20 mg x 30 film-coated tablets

NHIF code: CF997

ICD: I20.0; I20.1; I20.8; I20.9; I25.5; I69.0; I69.1; I69.2; I69.3; I69.4; I69.8

Alonzap

Description

Olanzapine is an atypical antipsychotic for the treatment of schizophrenia and bipolar disorder.

Indications

– Treatment of schizophrenia;

– Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response;

– Treatment of moderate to severe manic episodes;

– Prevention of recurrence in patients with bipolar disorder whose manic episode has responded to Olanzapine treatment.

Subject to medical prescription

Pharmaceutical form: 5 mg x 28 film-coated tablets

NHIF code: NF 696

ICD: F20.0, F20.1, F20.5, F20.6, F30.0, F30.1, F31.0, F31.1, F31.2, F31.6, F31.7

Pharmaceutical form: 10 mg x 28 film-coated tablets

NHIF code: NF 695

ICD: F20.0, F20.1, F20.5, F20.6, F30.0, F30.1, F31.0, F31.1, F31.2, F31.6, F31.7

Axid

Description

Nizatidine is a histamine H2-receptor antagonist that inhibits stomach acid production, and commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD)

Indications

Injectable Nizatidine is shown for hospitalized patients as alternative of oral drugs for short term period for peptic ulcer.

Subject to medical prescription

Pharmaceutical form: 25 mg/ml solution for infusion, 5 аmpoules x 4 ml